- Second-quarter revenue increased 10% annually to $63.5 billion, reflecting double-digit growth in revenue within U.S. Healthcare Solutions
- Reported earnings per share were $2.13 in the second quarter, down 18% from $2.59 reported in the previous year’s second quarter
- Gross profit moved up 2.7% year-over-year to $2.3 billion in the second quarter, reflecting higher gross profit in both reportable segments
- In Q2, operating expenses were $1.7 billion, which is up 19.2% compared to the same period in the previous fiscal year
- Reflecting the increase in operating expenses, second-quarter operating income decreased sharply to $560.5 million
Market News
A snapshot of AmerisourceBergen’s Q2 2023 earnings results
Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023. Second-quarter revenue increased 10% annually to $63.5 billion, reflecting double-digit growth in revenue within U.S. Healthcare Solutions Reported earnings per share were $2.13 in the second quarter, down 18% from $2.59 reported in the previous year’s […]
“Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023. Second-quarter revenue increased 10% annually to $63.5 billion, reflecting double-digit growth in revenue within U.S. Healthcare Solutions Reported earnings per share were $2.13 in the second quarter, down 18% from $2.59 reported in the previous year’s […]
· May 2, 2023
Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023.
ADVERTISEMENT